CIK: 1534265 - Address: 1350 Avenue of the Americas, Suite 2600, New York, NY 10019
18 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/6/24 19:20
3/4/24
LABStandard Biotools Inc.DEElectrLabEqLaboratory Analytical InstrumCasdin Partners Master Fund, L.P.NYDTP.m6462.570251123,094D
10/23/23 17:42
10/19/23
BLFSBiolife Solutions IncDEHealthElcMdElectromedical & ElectrotheraCasdin Partners Master Fund, L.P.NYTP10,37511.190927128,707D
8/11/23 17:01
8/9/23
BLFSBiolife Solutions IncDEHealthElcMdElectromedical & ElectrotheraCasdin Partners Master Fund, L.P.NYTP77213.2005817,780D
5/23/23 17:46
5/19/23
BLFSBiolife Solutions IncDEHealthElcMdElectromedical & ElectrotheraCasdin Partners Master Fund, L.P.NYTP.m1,67322.3207517,722I
5/19/23 21:00
5/17/23
LABStandard Biotools Inc.DEElectrLabEqLaboratory Analytical InstrumCasdin Partners Master Fund, L.P.NYDTP.m2,6312.1901,200New1,200I
5/18/23 20:31
5/16/23
BLFSBiolife Solutions IncDEHealthElcMdElectromedical & ElectrotheraCasdin Partners Master Fund, L.P.NYTP.m1,59521.2607517,647I
10/5/22 16:24
10/3/22
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiCasdin Partners Master Fund, L.P.NYTS-4,5256.150-736-710,000D
7/6/22 17:01
7/1/22
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiCasdin Partners Master Fund, L.P.NYTS-13,9134.300-3,236-2310,736D
8/4/21 18:33
8/3/21
TNYATenaya Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagCasdin Partners Master Fund, L.P.NYTP.d12,75015.000850362I
8/3/21 18:08
7/30/21
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiCasdin Partners Master Fund, L.P.NYTP23,40013.0001,8001513,971D
7/28/21 16:33
7/26/21
ABSIAbsci CorpDEHealthBiolabCommercial Physical & BiologiCasdin Partners Master Fund, L.P.NYDP.d25,00016.0001,563257,719M
6/22/21 17:12
6/21/21
VERVVerve Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCasdin Partners Master Fund, L.P.NYTP.d20,90019.0001,100832,418D
2/19/21 18:56
2/17/21
DBTXDecibel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsCasdin Partners Master Fund, L.P.NYTP.d10,35018.0005751051,121I
11/27/20 17:23
11/24/20
BLFSBiolife Solutions IncDEHealthElcMdElectromedical & ElectrotheraCasdin Partners Master Fund, L.P.NYTP36,00022.5001,600277,440D
7/2/20 16:48
7/1/20
BLFSBiolife Solutions IncDEHealthElcMdElectromedical & ElectrotheraCasdin Partners Master Fund, L.P.NYTP.m14,36314.500991205,840D
5/26/20 13:54
5/22/20
BLFSBiolife Solutions IncDEHealthElcMdElectromedical & ElectrotheraCasdin Partners Master Fund, L.P.NYTP5,00010.500476114,850D
5/18/20 16:47
5/14/20
BLFSBiolife Solutions IncDEHealthElcMdElectromedical & ElectrotheraCasdin Partners Master Fund, L.P.NYTP20,00010.5001,905774,373D
11/21/19 12:52
11/19/19
BLFSBiolife Solutions IncDEHealthElcMdElectromedical & ElectrotheraCasdin Partners Master Fund, L.P.NYTP.m61715.4104022,469D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact